TCL Archive GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer. November 2, 2007
TCL Archive Four Center Grants In Danger; Shingleton to Retire, Owen Promoted At Hopkins January 9, 1987
TCL Archive In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative” August 11, 1989
TCL Archive Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules July 30, 1999
